148 related articles for article (PubMed ID: 38177659)
1. Prediction of response to neoadjuvant chemo-immunotherapy in patients with esophageal squamous cell carcinoma by a rapid breath test.
Huang Q; Liu Z; Yu Y; Rong Z; Wang P; Wang S; Wu H; Yan X; Cho WC; Mu T; Li J; Zhao J; Qiu M; Hou Y; Li X
Br J Cancer; 2024 Mar; 130(4):694-700. PubMed ID: 38177659
[TBL] [Abstract][Full Text] [Related]
2. Assessment of an Exhaled Breath Test Using High-Pressure Photon Ionization Time-of-Flight Mass Spectrometry to Detect Lung Cancer.
Meng S; Li Q; Zhou Z; Li H; Liu X; Pan S; Li M; Wang L; Guo Y; Qiu M; Wang J
JAMA Netw Open; 2021 Mar; 4(3):e213486. PubMed ID: 33783517
[TBL] [Abstract][Full Text] [Related]
3. Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.
Ji G; Yang Q; Wang S; Yan X; Ou Q; Gong L; Zhao J; Zhou Y; Tian F; Lei J; Mu X; Wang J; Wang T; Wang X; Sun J; Zhang J; Jia C; Jiang T; Zhao MG; Lu Q
Genome Med; 2024 Apr; 16(1):49. PubMed ID: 38566201
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Breathomics Testing Using High-Pressure Photon Ionization Time-of-Flight Mass Spectrometry to Detect Esophageal Cancer.
Huang Q; Wang S; Li Q; Wang P; Li J; Meng S; Li H; Wu H; Qi Y; Li X; Yang Y; Zhao S; Qiu M
JAMA Netw Open; 2021 Oct; 4(10):e2127042. PubMed ID: 34609496
[TBL] [Abstract][Full Text] [Related]
5. Using clinical and radiomic feature-based machine learning models to predict pathological complete response in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiation.
Wang J; Zhu X; Zeng J; Liu C; Shen W; Sun X; Lin Q; Fang J; Chen Q; Ji Y
Eur Radiol; 2023 Dec; 33(12):8554-8563. PubMed ID: 37439939
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
7. To develop a prognostic model for neoadjuvant immunochemotherapy efficacy in esophageal squamous cell carcinoma by analyzing the immune microenvironment.
Yehan Z; Sheng Q; Hong Y; Jiayu L; Jun H; Juan J; Min S; Jiaxin Y; Shangzhi H; Yi W; Qifeng W; Xuefeng L; Wenwu H; Xueyan C; Yang L; Zongyao H
Front Immunol; 2024; 15():1312380. PubMed ID: 38726002
[TBL] [Abstract][Full Text] [Related]
8. The MRI radiomics signature can predict the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma.
Lu S; Wang C; Liu Y; Chu F; Jia Z; Zhang H; Wang Z; Lu Y; Wang S; Yang G; Qu J
Eur Radiol; 2024 Jan; 34(1):485-494. PubMed ID: 37540319
[TBL] [Abstract][Full Text] [Related]
9. Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath.
de Vries R; Muller M; van der Noort V; Theelen WSME; Schouten RD; Hummelink K; Muller SH; Wolf-Lansdorf M; Dagelet JWF; Monkhorst K; Maitland-van der Zee AH; Baas P; Sterk PJ; van den Heuvel MM
Ann Oncol; 2019 Oct; 30(10):1660-1666. PubMed ID: 31529107
[TBL] [Abstract][Full Text] [Related]
10. A CT-based novel model to predict pathological complete response of locally advanced esophageal squamous cell carcinoma to neoadjuvant PD-1 blockade in combination with chemotherapy.
Zhou HY; Guo WW; Ou J; Li R; Gui Y; Li L; Fu MY; Zhang XM; Chen TW
Eur J Radiol; 2023 Oct; 167():111065. PubMed ID: 37651827
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.
Zhang G; Yuan J; Pan C; Xu Q; Cui X; Zhang J; Liu M; Song Z; Wu L; Wu D; Luo H; Hu Y; Jiao S; Yang B
EBioMedicine; 2023 Apr; 90():104515. PubMed ID: 36921563
[TBL] [Abstract][Full Text] [Related]
13. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
Zhang X; Eyck BM; Yang Y; Liu J; Chao YK; Hou MM; Hung TM; Pang Q; Yu ZT; Jiang H; Law S; Wong I; Lam KO; van der Wilk BJ; van der Gaast A; Spaander MCW; Valkema R; Lagarde SM; Wijnhoven BPL; van Lanschot JJB; Li Z
BMC Cancer; 2020 Mar; 20(1):194. PubMed ID: 32143580
[TBL] [Abstract][Full Text] [Related]
16. Multidetector CT for Restaging Locally Advanced Esophageal Squamous Cell Carcinoma and Assessing Therapeutic Response to Neoadjuvant Chemotherapy.
Shi Y; Chen Y; Li X; Wang Z; Sun Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):133-139. PubMed ID: 28270296
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma.
Shen D; Chen Q; Wu J; Li J; Tao K; Jiang Y
J Gastrointest Oncol; 2021 Feb; 12(1):1-10. PubMed ID: 33708420
[TBL] [Abstract][Full Text] [Related]
18. Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study.
Gong L; Mao W; Chen Q; Jiang Y; Fan Y
Cancer Chemother Pharmacol; 2019 Apr; 83(4):639-647. PubMed ID: 30643929
[TBL] [Abstract][Full Text] [Related]
19.
Wang S; Di S; Lu J; Xie S; Yu Z; Liang Y; Gong T
Thorac Cancer; 2023 Aug; 14(24):2338-2349. PubMed ID: 37424279
[TBL] [Abstract][Full Text] [Related]
20. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
